share_log

华仁药业(300110.SZ):主要从事腹膜透析液、大输液、医疗器械等的研发、生产与销售

Huaren Pharmaceutical (300110.SZ): Mainly engaged in R&D, production and sales of peritoneal dialysis solutions, large infusions, medical devices, etc.

Gelonghui Finance ·  Mar 15 05:00

Gelonghui, March 15 | Huaren Pharmaceutical (300110.SZ) said on the investor interactive platform that the company is mainly engaged in R&D, production and sales of peritoneal dialysis solutions, large infusions (including non-PVC soft bags, upright soft bags, plastic bottles, large glass bottles), respiratory medicine, drugs in the field of refining, and raw materials, supporting pharmaceutical packaging materials, medical devices, etc. The X virus proposed by WHO does not represent a specific virus; it refers to a known or unknown virus that may infect humans on a large scale and cause public health events.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment